Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Abstract

Abstract Background Biologic therapies are widely used in patients with ulcerative colitis. Head-to-head trials of these therapies in patients with inflammatory bowel disease are lacking. Methods I...